journal article·2011-01

Macrophage-mediated degradation of crosslinked collagen scaffolds

A. Yahyouche, X. Zhidao, J.T. Czernuszka, A.J.P. Clover

Acta Biomaterialia· Volume 7· Issue 1
Publisher page

Abstract

Biological scaffolds used in tissue engineering are incorporated in vivo by a process of cellular in-growth, followed by host-mediated degradation and replacement of these scaffolds, in which phagocytic cells from the monocyte/macrophage cell lineage play a key role. The chemical degradation of scaffolds with collagenases is well established, but to date this has not been correlated with an in vitro model of cell mediated scaffold degradation. RAW264.7, a murine monocyte/macrophage cell line, was cultured on collagen scaffolds crosslinked either by dehydrothermal treatment (DHT) or by carbodiimide (EDC). These cells attached to collagen scaffolds, proliferated and exhibited macrophage aggregation to form giant cells. Crosslinking the scaffolds by either DHT or EDC increased the resistance of the scaffold to degradation by macrophages. Increasing the amount of crosslinking in the scaffold made them more resistant to degradation by collagenase. However, while EDC increased the scaffolds' thermal and mechanical properties and decreased the swelling ratio, DHT increased the mechanical properties, but decreased the denaturation temperature and swelling ratio. Altering the scaffold properties by crosslinking affects the rate of degradation by macrophages, and this is correlated with chemical degradation (r=0.658, p<0.01). This will help in the design of scaffolds with task-specific profiles for use in tissue engineering.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · 3D Printing in Biomedical Research · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (54)

Show source-provided references
1. In vitro degradation of three-dimensional porous poly(d,l-lactide-co-glycolide) scaffolds for tissue engineering10.1016/j.biomaterials.2004.01.038 ↗
2. Effect of chemical modifications on the susceptibility of collagen to proteolysis. II. Dehydrothermal crosslinking10.1016/S0141-8130(05)80002-9 ↗
3. Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases10.1016/S1074-5521(00)00077-6 ↗
4. Matrix metalloproteinases and the immune response10.1016/j.cair.2004.02.001 ↗
5. Matrix metalloproteinases (MMP): chemical–biological functions and (Q)SARs10.1016/j.bmc.2007.01.011 ↗
6. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments10.1074/jbc.270.11.5872 ↗
7. Animal collagenases: specificity of action, and structures of the substrate cleavage site10.1016/0006-291X(74)91000-6 ↗
8. Macrophage adhesion on gelatin-based interpenetrating networks grafted with PEGylated RGD10.1089/ten.2005.11.964 ↗
9. Integrin signalling in neutrophils and macrophages10.1016/S0898-6568(99)00003-0 ↗
10. Phagocytosis and remodeling of collagen matrices10.1016/j.yexcr.2006.12.019 ↗
11. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds10.1089/ten.tea.2008.0419 ↗
12. A review on macrophage responses to biomaterials10.1088/1748-6041/1/1/R01 ↗
13. Macrophage-mediated biodegradation of poly(dl-lactide-co-glycolide) in vitro10.1002/jbm.a.30853 ↗
14. Wound healing – aiming for perfect skin regeneration10.1126/science.276.5309.75 ↗
15. In vitro biodegradation of three brushite calcium phosphate cements by a macrophage cell-line10.1016/j.biomaterials.2006.04.030 ↗
16. Action of bacterial collagenase on Ascaris cuticle collagen10.1093/oxfordjournals.jbchem.a130996 ↗
17. Hydrolysis of synthetic peptides by collagenase10.1016/0006-3002(60)90531-X ↗
18. Identification of Clostridium histolyticum collagenase hyperreactive sites in type I, II, and III collagens: lack of correlation with local triple helical stability10.1007/BF01025095 ↗
19. Collagenase promotes the cellular responses to injury and wound healing in vivo
20. Enzymic degradation of collagen10.1016/B978-0-12-363707-9.50009-5 ↗
21. The collagen substrate specificity of rat uterus collagenase10.1016/S0021-9258(17)43838-5 ↗
22. Clostridium histolyticum collagenases: a new look at some old enzymes
23. Polymeric collagen fibrils. An example of substrate-mediated steric obstruction of enzymic digestion10.1016/0005-2744(76)90066-8 ↗
24. Effect of physical crosslinking methods on collagen-fiber durability in proteolytic solutions10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M ↗
25. The effect of two types of cross-linking on some mechanical properties of collagen
26. Methods for the treatment of collagenous tissues for bioprostheses10.1016/S0142-9612(96)00106-8 ↗
27. Biocompatibility and tissue regenerating capacity of crosslinked dermal sheep collagen10.1002/jbm.820280310 ↗
28. Effects of carbodiimide crosslinking conditions on the physical properties of laminated intestinal submucosa10.1002/1097-4636(200107)56:1<101::AID-JBM1074>3.0.CO;2-6 ↗
29. Stabilization of low denaturation temperature collagen from fish by physical cross-linking methods10.1016/S1389-1723(04)70152-8 ↗
30. Controlling the processing of collagen-hydroxyapatite scaffolds for bone tissue engineering10.1007/s10856-006-0682-9 ↗
31. Influence of telopeptides, fibrils and crosslinking on physicochemical properties of Type I collagen films
32. Angele · Biomaterials · 2004 · 25 · 283110.1016/j.biomaterials.2003.09.066 ↗
33. Buttafoco · J Biomed Mater Res B: Appl Biomater · 2006 · 77 · 35710.1002/jbm.b.30444 ↗
34. Evaluation of collagen crosslinking techniques10.3109/10731198309118815 ↗
35. Role of collagenous matrices in the adhesion and growth of cells10.1083/jcb.88.3.473 ↗
36. Activation of alveolar macrophages by native and synthetic collagen-like polypeptides10.1165/ajrcmb.10.1.8292381 ↗
37. Influence of different crosslinking treatments on the physical properties of collagen membranes10.1016/S0142-9612(02)00412-X ↗
38. Correlation of in vivo collagen degradation rate with in vitro measurements10.1002/jbm.820090608 ↗
39. Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro10.1161/01.ATV.18.3.432 ↗
40. Use of diphenylphosphorylazide for cross-linking collagen-based biomaterials10.1002/jbm.820280204 ↗
41. Mouse fibroblasts in long-term culture within collagen three-dimensional scaffolds: influence of crosslinking with diphenylphosphorylazide on matrix reorganization, growth, and biosynthetic and proteolytic activities10.1002/(SICI)1097-4636(20000315)49:4<448::AID-JBM3>3.0.CO;2-L ↗
42. Degradation of a collagen-chondroitin-6-sulfate matrix by collagenase and by chondroitinase10.1016/S0142-9612(03)00541-6 ↗
43. Gotora D. DPhil thesis, Oxford University; 2005. p. 77 [Chapter 4].
44. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
45. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions10.1084/jem.20070885 ↗
46. The influence of crosslinking agents and diamines on the pore size, morphology and the biological stability of collagen sponges and their effect on cell penetration through the sponge matrix10.1023/A:1017989305873 ↗
47. Wissink · Thromb Haemost · 2000 · 84 · 32510.1055/s-0037-1614015 ↗
48. Surface characterization of collagen/elastin based biomaterials for tissue regeneration10.1016/j.apsusc.2009.05.127 ↗
49. Ma · Biomaterials · 2003 · 24 · 483310.1016/S0142-9612(03)00374-0 ↗
50. Characterization of porous collagen/hyaluronic acid scaffold modified by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide cross-linking10.1016/S0142-9612(01)00235-6 ↗
51. Cell size of alveolar macrophages: an interspecies comparison
52. Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases10.1189/jlb.0306152 ↗
53. Matrix metalloproteinases in immunity10.4049/jimmunol.156.1.1 ↗
54. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages10.1016/S0021-9258(20)80459-1 ↗